Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan

Hisamitsu Pharmaceutical Co., Ltd, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., is a Taiwanese company located in Taipei. The firm manufactures and markets pharmaceuticals.

Lion Corp. engages in the manufacture and sale of dental and body care, laundry, household cleaners, pharmaceuticals, and health products. It operates through the following business segments: Consumer Products, Industrial Products, Overseas, and Other. The Consumer Products segment manufactures and sells daily necessities, over-the-counter drugs and function food. These include toothpaste, toothbrush, hand soap, antipyretic analgesic, eye drops, nutritional drink, laundry detergent, softener, and bleach. The Industrial Products segment provides chemical raw materials and business supplies. These include oil and fat activator, conductive carbon, and professional cleaning agent. The Overseas segment handles the operation of overseas subsidiaries that manufactures and sells daily commodities. The Other segment includes construction contracting, real estate management, transportation storage, and staffing. The company was founded by Tomijiro Kobayashi on October 30, 1891 and is headquartered in Tokyo, Japan.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan.

Guangdong Zhongke Pharmaceutical Research Co., Ltd., established on 2005-12-20, The scope of business includes the research and development of pharmaceuticals,Chemical raw materials(Free of Hazardous Chemicals)promotion of,Research,to develop.

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company operates through the following business divisions: Pharmaceuticals manufacturing and distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials manufacturing and distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections. The company was founded by Kim Ki-Yong on January 19, 1984 and is headquartered in Hoengseong-gun, South Korea.

Oishi Koseido provides adhesive transdermal patches, Non-prescription and prescription pharmaceuticals.

Shandong Haiyou Freda Pharmaceutical Co., Ltd., established on 2012-08-14, Business scope includes raw materials(felbinac,Grecht,Tadalafil,Obuvacaine Hydrochloride)production and sales of,Pharmaceutical Intermediates(Amino nitrogen heterocycle hydrochloride,p-Toluenesulfonylurea,Zinc hydroxide,ammonium chloride,cis-(1R,3R)-1,2,3,4-Tetrahydro-1-(3,4-Methylenedioxyphenyl)-9H-pyrido[3,4-B]indole-3-Methyl carboxylate hydrochloride,1,2,3,4-Tetrahydro-2-Chloroacetyl- 1-(3,4-Methylenedioxyphenyl)-9h-pyrido[3,4-b]indole-3-carboxylic acid-(6R,12ar)-methyl ester)production and sales of,Production and sales of hydroxytyrosol,Technology Development and Technical Services,Domestic Trade,Import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hubei Xunda Pharmaceutical Co., Ltd. (迅达药业) is a modern Chinese pharmaceutical enterprise that produces anti-inflammatory and analgesic drugs, and bulk pharmaceutical chemicals for antibiotics and pharmaceutical intermediates. Hubei Xunda Pharmaceutical’s main product portfolio includes ketoprofen, felbinac, fosfomycin calcium, fosfomycin sodium, fosfomycin trometamol, cyano ketone ibuprofen, loxoprofen sodium, and more. These products have been sold to countries and regions such as Japan, Korea, the Middle East, Europe, and America. The company owns advanced production equipment, complete testing equipment, technical forces, scientific and standard management solutions, and a number of invention patents. Hubei Xunda Pharmaceutical has gotten through the Chinese GMP certification and official GMP on-site audit of JMHW, while its ketoprofen product has obtained the European COS certificate.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Daiichi Sankyo Healthcare Co., Ltd. engages manufacture and sale of pharmaceutical products. It produces and supplies over-the-counter drugs, quasi drugs, cosmetics, medical equipment, food, and beverages. The company was founded on December 16, 2005 and is headquartered in Tokyo, Japan.

Shanghai Tupa Pharmaceutical Technology Co., Ltd., established on 2010-03-17, Business scope includes medical consultation(Do not engage in medical activities,psychological counseling),Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),business inquiries,Business Management Consulting,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Sales of packaging materials.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Lintec Corp. develops, manufactures, and sells pressure-sensitive adhesive materials in Japan and internationally.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.